Page 3 - Best Chondrosarcoma doctors: TOP 62 doctors

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Eytan Aharon Ben‑Ami, MD, is a Senior Physician in the Sarcoma and Bone Oncology Service at Sheba Medical Center. He heads the Oncology Division and the Early-Phase Clinical Trials Unit. He founded the Sheba Clinical Research Organization. He is an academic affiliate at Tel Aviv University.

He specializes in sarcomas and primary bone tumors, including soft tissue sarcoma, liposarcoma, leiomyosarcoma, and osteosarcoma. He leads Phase I trials in targeted therapy and immunotherapy. He designs personalized treatment plans for rare cancers. He also develops patient-centered programs, including pilots in advanced immunotherapy delivery.

He completed a fellowship in Sarcoma and Bone Oncology at the Dana-Farber Cancer Institute/Harvard Cancer Center. He has authored more than 40 publications on early detection, molecular and viral mechanisms, and new cancer therapies.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Specialized in radiation oncology at Marmara University, focusing on chondrosarcoma treatment.

• Trained at renowned Marmara University Faculty of Medicine
• Specialization in radiation oncology from 2012-2016
• Graduated from Marmara University Faculty of Medicine (English) undergraduate program
• Dedicated to providing personalized radiation therapy plans

Professor Ersin Ozturk brings over 28 years of experience of surgical expertise, specializing in complex cases at Medicana Bursa Hospital.

• Board-certified in general surgery and surgical oncology
• Fellowship-trained at Cleveland Clinic in colorectal surgery
• Professor of medicine with academic roles at multiple universities
• Expert in laparoscopic and minimally invasive techniques

Dr. Sridhar P.S. specializes in radiotherapy for chondrosarcoma, bringing extensive training and professional recognition to his practice at HCG Manavata Cancer Centre.

• Board-certified in radiotherapy with over 30 years of experience of experience
• Member of the Society for Neuro-Oncology and other prestigious groups
• Trained at Banaras Hindu University and holds a Diplomate of National Board

Dr. Chaitainya Borde has handled over 30,000 PET scans and 1,000 thyroid cancer patients at HCG Manavata Cancer Centre.

• 11 years of experience of experience in nuclear medicine
• Specializes in radioiodine and Lu-177 RN therapies
• Published research in medical journals
• Skilled in PET-CT scans and nuclear cardiology

Dr. Shruti Kate specializes in advanced cancer treatments, including immunotherapy and metronomic therapy for chondrosarcoma. She trained at Tata Memorial Hospital – India's leading cancer center.

• Expert in lung, breast, and genitourinary cancers
• Presented research at World Conference on Lung Cancer
• Member of ASCO, ESMO, and other top oncology societies
• Uses Whipple procedure for complex cases

50,000+ cancer surgeries over 30 years of experience – Dr. Nagarkar specializes in complex tumor removal while preserving quality of life at HCG Manavata Cancer Centre.

• Trained at Tata Memorial Hospital and Royal College of Surgeons
• Conducted 200+ clinical trials on new cancer treatments
• Professor for DNB Superspecialty Surgical Oncology
• Special focus on breast and thoracic oncology

Specialist in Orthopedic Surgery and Traumatology at Clinica Universidad de Navarra.

• Expertise in musculoskeletal tumor treatment
• Focuses on surgical interventions for bone tumors
• Works at a leading university hospital

Over 15,000 successfully conducted cancer surgeries – Dr. Sundaram specializes in complex oncological cases at Global Hospital Chennai.

• of experience in surgical oncology
• Expert in handling high-risk and advanced cases
• Focuses exclusively on cancer surgeries

Associate Professor Dr. Emrah Eraslan specializes in oncology with extensive experience in treating various cancers, including Chondrosarcoma, at Koru Ankara Hospital.

• Board-certified in internal medicine and medical oncology
• Trained at Dr. Abdurrahman Yurtaslan Ankara Oncology Education and Research Hospital
• Published multiple research papers in oncology
• Current associate professor contributing to advancements in cancer treatment